PathAI, Inc.
PathAI is dedicated to improving patient outcomes through reliable AI-powered pathology technology and collaboration with biopharma and pathology laboratories. They develop comprehensive precision pathology solutions, leveraging data from over 15 million annotations and a network of over 450 pathologists, to accelerate drug development, improve diagnostic accuracy, and facilitate life-saving therapies. Their mission is to transform pathology with AI models that support research, clinical trials, and diagnostic use, aiming for more accurate diagnoses, better treatment matching, and increased drug approvals.
Industries
Nr. of Employees
medium (51-250)
Products
Digital pathology image management system
Cloud-native enterprise image management and workflow platform that hosts whole-slide images, manages cases, and deploys AI analytics for research and clinical use.
AI-based biomarker and histology feature panels
Pre-built and custom AI panels for quantifying biomarkers (e.g., HER2, ER, PR, Ki-67, PD-L1) and extracting spatial histopathology features for oncology, NASH/MASH, and IBD research.
Validated disease-specific AI scoring assays
Research-use AI assays that output standardized scores and metrics (for example: PD-L1 percent positive, HER2 scores, Ki-67 percent positive, and histologic index conversions for ulcerative colitis).
Digital pathology image management system
Cloud-native enterprise image management and workflow platform that hosts whole-slide images, manages cases, and deploys AI analytics for research and clinical use.
AI-based biomarker and histology feature panels
Pre-built and custom AI panels for quantifying biomarkers (e.g., HER2, ER, PR, Ki-67, PD-L1) and extracting spatial histopathology features for oncology, NASH/MASH, and IBD research.
Validated disease-specific AI scoring assays
Research-use AI assays that output standardized scores and metrics (for example: PD-L1 percent positive, HER2 scores, Ki-67 percent positive, and histologic index conversions for ulcerative colitis).
Services
Translational research services
AI-powered biomarker discovery, spatial histopathology feature extraction, and custom algorithm development to support translational research across oncology, liver disease, and inflammatory bowel disease.
Clinical trial pathology services
End-to-end support for clinical trials including regulated prospective algorithm development, core pathology operations, expert manual review, and pathology protocol strategy.
Diagnostic development and commercialization support
Coordinated design, development, and validation services for software-as-a-medical-device and companion diagnostics, including regulatory and market access strategy.
Real-world histopathology data licensing
Licensing of quantitative histopathology data products linked to structured clinical and molecular datasets for biomarker discovery and validation.
In-house histopathology laboratory services
Regulated laboratory operations providing sample receipt, processing, staining (H&E, IHC, special stains), multiplex assays, slide scanning, storage, and slide-level scoring.
Translational research services
AI-powered biomarker discovery, spatial histopathology feature extraction, and custom algorithm development to support translational research across oncology, liver disease, and inflammatory bowel disease.
Clinical trial pathology services
End-to-end support for clinical trials including regulated prospective algorithm development, core pathology operations, expert manual review, and pathology protocol strategy.
Diagnostic development and commercialization support
Coordinated design, development, and validation services for software-as-a-medical-device and companion diagnostics, including regulatory and market access strategy.
Real-world histopathology data licensing
Licensing of quantitative histopathology data products linked to structured clinical and molecular datasets for biomarker discovery and validation.
In-house histopathology laboratory services
Regulated laboratory operations providing sample receipt, processing, staining (H&E, IHC, special stains), multiplex assays, slide scanning, storage, and slide-level scoring.
Expertise Areas
- Digital pathology and image management
- AI-driven biomarker quantification and spatial analysis
- Clinical trial pathology services
- Assay development and validation for tissue-based methods
Key Technologies
- Whole-slide imaging (WSI)
- Deep learning for histopathology
- Graph neural networks (GNNs)
- Multiple instance learning (MIL)